1 / 6

World Leukemia Therapeutics Market - Opportunities and Forecasts, 2017-2023

Leukemia is a burgeoning blood cancer that forms in the bone marrow and eventually leads to the uncontrolled growth of blood cells. Amid other cancer types, Leukemia is emerging as a life impinging threat, globally.<br>Get more information at : https://www.alliedmarketresearch.com/request-toc-and-sample/1447

shawn966
Télécharger la présentation

World Leukemia Therapeutics Market - Opportunities and Forecasts, 2017-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. World Leukemia Therapeutics Market Opportunities and Forecasts, 2017-2023

  2. Leukemia is a burgeoning blood cancer that forms in the bone marrow and eventually leads to the uncontrolled growth of blood cells. Amid other cancer types, Leukemia is emerging as a life impinging threat, globally. . According to the National Cancer Institute (NCI), leukemia would account for about 24.450 deaths in U.S., in 2015. Furthermore, there were 318,389 leukemia patients in the U.S. in 2012 with about 54,270 new cases anticipated in 2015. Rising incidences and high mortality rates caused by leukemia have created an indispensable need for leukemia therapeutics in the market.

  3. While the market is regularly flooded with breakthrough treatments, there still exists an unmet medical need in the market. The leukemia therapeutics market would continue to linger in the spotlight, primarily due to rising incidences of leukemia, strong developing pipeline and targeted drug delivery. However, the limited availability of treatment and erosion by generics is likely to curtail the market growth • The lack of early diagnosis and awareness among public are leading challenges in the market. Moreover, redefining the drug lifecycle roadmap is a major challenge for drug innovators. However, breakthrough therapy designations and accelerated approvals granted by regulatory bodies such as FDA, would provide lucrative market opportunities for the drug innovators.

  4. KEY MARKET BENEFITS: • This report provides an extensive analysis of the current and emerging market trends and dynamics in the Global Leukemia Therapeutics market. • Extensive research is done for the market by therapy type which instils a clear understanding regarding the currently used chemotherapy and targeted therapy drugs • The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities • The leukemia therapeutics market scenario is comprehensively analysed in accordance with the key regions

  5. major market players : • Novartis AG • Pfizer Inc. • Sanofi • Roche Holding AG • Celgene Corporation • Bristol-Myers Squibb (BMS)

  6. KEY MARKET SEGMENTS: • Leukemia Therapeutics Market By Type • Chemotherapy • Biological Therapy • Radiation therapy • Targeted therapy

More Related